Krystal Biotech, Inc. (KRYS) Free cash flow 2016–2025
Krystal Biotech, Inc. (KRYS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$188.9MFY2025 · since FY2016: -$1.3M → $188.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $188.9M | +58.5% |
| FY2024 | $119.2M | +218.5% |
| FY2023 | -$100.6M | +34.5% |
| FY2022 | -$153.5M | -32.1% |
| FY2021 | -$116.3M | -184.1% |
| FY2020 | -$40.9M | -63.1% |
| FY2019 | -$25.1M | -114.8% |
| FY2018 | -$11.7M | -184.9% |
| FY2017 | -$4.1M | -209.2% |
| FY2016 | -$1.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More KRYS financial trends
KRYS RevenueKRYS Net incomeKRYS Net marginKRYS Gross profitKRYS Gross marginKRYS Operating incomeKRYS Operating marginKRYS Operating cash flowKRYS Capital expendituresKRYS Return on equityKRYS Stock buybacksKRYS Dividends paidKRYS Total assetsKRYS Total liabilitiesKRYS Shareholders’ equityKRYS overview →